What is the recommended dosage of ampicillin (Ampicillin) for treating Enterococcus Faecalis (E. Faecalis) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ampicillin Dosing for Enterococcus Faecalis Infections

For Enterococcus faecalis infections, the recommended dosage of ampicillin is 2g IV every 4-6 hours for uncomplicated infections, with treatment duration of 7-14 days, and extending to 4-6 weeks for endocarditis or other deep-seated infections. 1

Dosing Considerations Based on Infection Type

Uncomplicated Infections

  • Ampicillin: 2g IV every 4-6 hours for 7-14 days 1
  • For urinary tract infections without systemic involvement, shorter courses (5-7 days) may be sufficient

Invasive Infections (Bacteremia, Endocarditis)

  • Ampicillin: 2g IV every 4 hours (12g/day) for 4-6 weeks 2
  • For native valve endocarditis: 4-6 weeks of therapy 2
  • For prosthetic valve endocarditis: 6 weeks of therapy 2

Combination Therapy Options

Traditional Approach: Ampicillin plus Aminoglycoside

  • Historically, ampicillin plus gentamicin was the standard regimen for serious E. faecalis infections
  • However, this combination has significant limitations:
    • High risk of nephrotoxicity, especially in elderly patients or those with renal impairment 1
    • Ineffective against high-level aminoglycoside-resistant (HLAR) strains 3

Modern Approach: Ampicillin plus Ceftriaxone

  • Ampicillin: 2g IV every 4 hours plus Ceftriaxone: 2g IV every 12 hours 3
  • This combination is now preferred because:
    • Similar efficacy to ampicillin-gentamicin (no difference in mortality or treatment failure) 3
    • Significantly lower risk of adverse events (1% vs 25%, p<0.001) 3
    • Effective against both aminoglycoside-susceptible and HLAR strains 4, 3
    • No risk of nephrotoxicity compared to aminoglycoside regimens 3

Special Considerations

Penicillin Allergy

  • For patients with non-anaphylactic penicillin allergy, consider penicillin desensitization 2
  • If beta-lactams cannot be given:
    • Vancomycin: 30 mg/kg/day IV in 2-3 divided doses 2
    • For serious infections in penicillin-allergic patients, vancomycin plus gentamicin may be considered (if renal function permits)

High-Level Aminoglycoside Resistance (HLAR)

  • Aminoglycosides should not be used if HLAR is present (MIC >500 mg/L) 2
  • Ampicillin plus ceftriaxone is the preferred regimen for HLAR strains 4, 3

Renal Impairment

  • Ampicillin-ceftriaxone is preferred over aminoglycoside-containing regimens 1, 3
  • Dose adjustment of ampicillin may be needed in severe renal impairment

Monitoring Recommendations

  • Clinical response should be assessed within 48-72 hours of starting treatment
  • For endocarditis, blood cultures should be repeated to confirm clearance of bacteremia
  • Regular monitoring of renal function, especially if aminoglycosides are used

Common Pitfalls to Avoid

  • Underestimating treatment duration for invasive infections
  • Using aminoglycosides in patients with pre-existing renal impairment
  • Failing to identify high-level aminoglycoside resistance
  • Not considering the possibility of endocarditis in patients with E. faecalis bacteremia
  • Using monotherapy for serious or invasive E. faecalis infections

The ampicillin plus ceftriaxone combination has emerged as the preferred regimen for serious E. faecalis infections due to its efficacy against both aminoglycoside-susceptible and resistant strains, along with its superior safety profile compared to aminoglycoside-containing regimens.

References

Guideline

Treatment of Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.